Melanie Sobczyk

Q: What is Melanie Sobczyk email address?

Email Melanie Sobczyk at melsobczyk@gmail.com and melanie.sobczyk@novartis.com. This email is the most updated Melanie Sobczyk's email found in 2026.

Q: How to contact Melanie Sobczyk?

To contact Melanie Sobczyk send an email to melsobczyk@gmail.com or melanie.sobczyk@novartis.com. (updated on April 10, 2025)

Director, Global RLT Partnership Strategy at Novartis | Basel, Basel, Switzerland

About Melanie Sobczyk

Melanie Sobczyk currently serves as the Director of Global RLT Partnership Strategy at Novartis, where she plays a pivotal role in advancing Radioligand Therapy (RLT) within the oncology landscape. Leveraging over two decades of expertise across biochemistry, clinical neuroscience, and strategic consultancy, Melanie has established herself as a key driver in fostering innovative collaborations that enhance patient access and treatment outcomes. Her focus on global healthcare system readiness and strategic partnerships ensures that cutting-edge RLT therapies are seamlessly integrated into diverse healthcare settings worldwide.

In her role, Melanie spearheads initiatives that align scientific advancements with healthcare system capabilities, working closely with cross-functional teams to develop comprehensive strategies for RLT deployment. Her leadership in establishing partnerships with healthcare providers, payers, and regulatory bodies has been instrumental in overcoming barriers to access and optimizing the delivery of targeted radioligand therapies. Melanie’s expertise in medical education and healthcare systems allows her to translate complex scientific innovations into practical, scalable solutions that benefit patients suffering from various oncology indications.

Key projects under her stewardship include the development of global frameworks for HCS readiness, strategic engagement with key opinion leaders, and the implementation of educational programs to elevate understanding of RLT among healthcare professionals. Her deep understanding of oncology, infectious diseases, and cardiovascular considerations informs her approach to creating sustainable, patient-centric strategies. Melanie’s commitment to advancing healthcare through strategic partnerships and innovative science positions her as a vital leader in the evolving field of radioligand therapy, ultimately driving progress in personalized cancer treatment worldwide.

Melanie Sobczyk Work